EN
中文
EN
Who We Are
Newsroom
Innovation
Products
Investor Relations
Careers
Contact Us
Information Disclosure
Home
>
Investor Relations
>
Information Disclosure
H Share
THIRD QUARTERLY REPORT FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2022
DISCLOSEABLE TRANSACTION PURCHASE OF STRUCTURED DEPOSITS
NOTICE OF BOARD MEETING
Monthly Return of Equity Issuer on Movements in Securities
DISCLOSEABLE TRANSACTION PURCHASE OF STRUCTURED DEPOSITS
Notification Letter and Request Form to Non-registered Shareholders
Interim Report 2022
Monthly Return of Equity Issuer on Movements in Securities
INSIDE INFORMATION RECOMBINANT COVID-19 VACCINE (ADENOVIRUS TYPE 5 VECTOR) FOR INHALATION INCLUDED FOR EMERGENCY USE AS BOOSTER VACCINE IN CHINA
INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED JUNE 30, 2022
1
22
23
24
25
26
52
津公网安备12011602300399
